Anti-hypertensive Drugs Market To Reach $35.32 Billion By 2033

October 2025 | Report Format: Electronic (PDF)

Anti-hypertensive Drugs Market Growth & Trends

The global anti-hypertensive drugs market size is estimated to reach USD 35.32 billion by 2033, registering a CAGR of 3.96% from 2025 to 2033, according to a new report by Grand View Research, Inc. Rising patient base of high blood pressure is the primary factor propelling market growth. Moreover, increasing cases of chronic diseases such as obesity, cancer, and heart disease and innovations in drug discovery & personalized medicine are increasing the growth of anti-hypertensive drugs market.

Presence of strong product in the pipeline demonstrating positive results is a major factor driving the demand for anti-hypertensive drugs market. For instance, in September 2023, Alnylam Pharmaceuticals, Inc. announced the phase 2 study on an investigation drug for the treatment of hypertension, zilebesiran, met the primary end-point and demonstrated significant reduction in the systolic BP (24 hour mean). Zilebesiran is an RNAi therapeutic targeting angiotensinogen which is administered subcutaneously and is expected to target high unmet need in populations.

The growing prevalence of diabetes is fueling the anti-hypertensive drugs market growth, as hypertension is a common complication of diabetes. Over time, hypertension can damage the heart, blood vessels, kidneys, and other organs. As the prevalence of diabetes is growing, the demand for anti-hypertensive drugs is expected to increase. According to the IDF Diabetes Atlas 10th edition 2021, an estimated 537 million adults between the ages of 20-79 years are living with diabetes, and it is expected to reach 643 million by 2030.

Government funding for R&D activities and distribution is playing a role in boosting the market growth by making anti-hypertensive drugs more affordable, improving access, and increasing competition. For instance, in August 2023 , Eazymed Technologies Pvt Ltd. raised USD 500,000 from the Tamil Nadu Emerging Sector Seed Fund in India. The company will utilize the fund on new ventures in the supply chain, such as working directly with pharmaceutical companies to expand their presence in tier 2-3 cities. Such initiatives are boosting the anti-hypertensive drugs market growth.

Moreover, rising approvals of new anti-hypertensive drugs encourage pharmaceutical companies to invest in research & development of novel and effective treatment options, which is expected to offer lucrative opportunities for the key players. For instance, in May 2022, the FDA approved Tyvaso DPI (treprostinil) inhalation powder. Tyvaso DPI is a dry powder inhaler that delivers treprostinil, a vasodilator, directly to the lungs. Treprostinil works by dilating the pulmonary arteries, which reduces blood pressure in the lungs and improves exercise capacity.

key Request a free sample copy or view report summary: Anti-hypertensive Drugs Market Report

Anti-hypertensive Drugs Market Report Highlights

By product, the angiotensin II receptor blockers (ARBs) segment led the market with the largest revenue share of 23.73% in 2024.
By type, the standard hypertension segment led the market with a share of 87.75% in 2024, due to the high prevalence of patients whose blood pressure can be controlled with one to three antihypertensive agents.
By route of administration, the oral segment led the market with the largest revenue share of 91.88% in 2024, owing to its convenience, ease of administration, and high patient compliance.
By distribution channel, the retail pharmacy segment led the market with the largest revenue share of 47.95% in 2024, driven by easy accessibility, widespread presence in urban and rural areas, and the ability to provide prescription and over-the-counter antihypertensive medications.
North America anti-hypertensive drugs market dominated the global industry with the largest revenue share of 35.61% in 2024, driven by the high prevalence of hypertension and advanced healthcare infrastructure.

Anti-hypertensive Drugs Market Segmentation

Grand View Research has segmented the global anti-hypertensive drugs market based on product, type, route of administration, distribution channel, and region:

Anti-hypertensive Drugs Product Outlook (Revenue, USD Million, 2021 - 2033)